Strikingly, many other kinase-activating fusions that phenocopy BCR-ABL1 are now recognised in B-ALL, and characterise the new Ph-like B-ALL entity [4]. Here, ABL1 is linked to precursor B-cell acute lymphoblastic leukemia.